HK1105892A1 - Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture - Google Patents

Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

Info

Publication number
HK1105892A1
HK1105892A1 HK08100069.8A HK08100069A HK1105892A1 HK 1105892 A1 HK1105892 A1 HK 1105892A1 HK 08100069 A HK08100069 A HK 08100069A HK 1105892 A1 HK1105892 A1 HK 1105892A1
Authority
HK
Hong Kong
Prior art keywords
amine polymers
aliphatic amine
methods
manufacture
pharmaceutical formulations
Prior art date
Application number
HK08100069.8A
Other languages
English (en)
Inventor
Julia Hrakovsky
Ruth Tenengauzer
Alla Ioffe
Eleonora Moin-Kotliar
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HK1105892A1 publication Critical patent/HK1105892A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK08100069.8A 2006-02-14 2008-01-04 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture HK1105892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06250788A EP1818048B1 (en) 2006-02-14 2006-02-14 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

Publications (1)

Publication Number Publication Date
HK1105892A1 true HK1105892A1 (en) 2008-02-29

Family

ID=36716993

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08100069.8A HK1105892A1 (en) 2006-02-14 2008-01-04 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

Country Status (8)

Country Link
EP (1) EP1818048B1 (es)
AT (1) ATE419838T1 (es)
DE (1) DE602006004695D1 (es)
DK (1) DK1818048T3 (es)
ES (1) ES2320265T3 (es)
HK (1) HK1105892A1 (es)
PL (1) PL1818048T3 (es)
PT (1) PT1818048E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964182B2 (en) 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
MX2011007760A (es) * 2009-01-22 2011-08-17 Usv Ltd Composiciones farmaceuticas que comprenden polimero vinculante a fosfato.
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
US9566299B2 (en) * 2013-02-08 2017-02-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
WO2020138921A1 (ko) * 2018-12-24 2020-07-02 동인당제약 주식회사 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
RU2241462C2 (ru) * 2000-07-28 2004-12-10 Ф. Хоффманн-Ля Рош Аг Новая фармацевтическая композиция

Also Published As

Publication number Publication date
ATE419838T1 (de) 2009-01-15
DE602006004695D1 (de) 2009-02-26
PT1818048E (pt) 2009-03-11
EP1818048A1 (en) 2007-08-15
EP1818048B1 (en) 2009-01-07
PL1818048T3 (pl) 2009-06-30
DK1818048T3 (da) 2009-04-20
ES2320265T3 (es) 2009-05-20

Similar Documents

Publication Publication Date Title
RS50812B (sr) Suva granulisana kompozicija koja sadrži emtricitabin i tenofovir df
TW200621268A (en) Antimicrobial copolymers and uses thereof
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
NO20090554L (no) Farmasoytiske preparater av memantin
WO2006010423A3 (en) Azaindole inhibitors of mtp and apob
WO2011076749A3 (en) Solid pharmaceutical dosage form of ticagrelor
HK1111609A1 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
EP3626253A3 (en) Stable formulations of linaclotide
MY138308A (en) Hiv replication inhibiting pyrimidines and triazines
WO2010111640A3 (en) Anti-influenza formulations and methods
HK1105892A1 (en) Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
WO2008064202A3 (en) Modified-release formulations of calcium receptor-active compounds
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
MX2010004899A (es) Conjugados de neurturina novedosos para uso farmaceutico.
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
HK1120417A1 (en) Stable nanoparticle formulations
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
TW200640472A (en) Solid pharmaceutical composition comprising telithromycin
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM TEVA PHARMACEUTICAL INDUSTRIES, INC. TO TEVA PHARMACEUTICAL INDUSTRIES, LTD.

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130214